STAGE II OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Clinical trials for STAGE II OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new STAGE II OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for STAGE II OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Targeted treatment tested for HPV-Linked throat cancers

Disease control Completed

This study tested whether giving radiation therapy twice daily along with a chemotherapy drug called docetaxel could better control cancer that returns after surgery for HPV-related throat cancer. The trial involved 81 patients who had their tumors surgically removed but were at …

Matched conditions: STAGE II OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

STAGE II OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Get alerted when new STAGE II OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear

Targeted treatment tested for HPV-Linked throat cancers